Investigational Site Number : 2030006

Pardubice 53203

0 studies enrolling now · 3 studies all time

What they study most

Cutaneous Lupus Erythematosus, Relapsing Multiple Sclerosis

Studies at this site

• Long Term Safety and Efficacy Study of Tolebrutinib (SAR442168) in Participants With Relapsing Multiple Sclerosis — Completed
• Dose-finding Study for SAR442168 in Relapsing Multiple Sclerosis — Completed
• Proof of Concept Study of SAR443122 in Patients With Cutaneous Lupus Erythematosus — Completed